Regulation of herpes simplex virus-specific lymphoproliferation by suppressor cells.

Journal of Virology (Impact Factor: 4.65). 11/1985; 56(1):1-6.
Source: PubMed

ABSTRACT We investigated the regulation of the herpes simplex virus (HSV)-specific lymphoproliferative response (LPR) by suppressor cells. The chief cell types in HSV-immune splenocytes proliferating in response to the antigen were Lyt 1+ and Lyt 2+ T cells, which accounted for approximately 60 and 40% of the response, respectively. Because the total responsiveness of splenocytes was enhanced after depletion of Lyt 2+ cells, the LPR was assumed to be subject to regulation by an Lyt 2+ suppressor cell. This was shown to be the case with an experimental design in which suppressor cell activity was induced in one culture, the cells were irradiated, and the effects on LPR were measured in a test antigen-stimulated culture. The cell responsible for suppression was shown to be Lyt 2+ IJ+, and the actual suppressor effect was not antigen specific. Cellular requirements for the generation of suppression were also investigated. The three distinct cell types that appeared to be required were Lyt 2+ and Lyt 1+ T cells and an IJ+ antigen-presenting cell. Of the three cell types, only the Lyt 2+ cell needed to be from HSV-immune animals. The implications of our model system for the better understanding of the role of immunity in herpesvirus pathogenesis are discussed.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Mice, guinea pigs, and rhesus monkeys were immunized with immunoaffinity-purified native glycoprotein D (gD) derived from herpes simplex virus type 1 (HSV1). The native glycoprotein has evoked significant in vivo responses even at low doses. Thus, mice immunized with doses as low as 1 microgram were significantly protected from the morbidity and mortality of lethal HSV2 challenge and from establishment of latent HSV2 infection. Protection was dose-related and correlated with prechallenge serum neutralizing antibody titres to HSV. Similarly, immunized guinea-pigs demonstrated significant reductions in the frequency, severity and duration of genital lesions induced by HSV2 vaginal challenge. In long term immunogenicity studies, immunized rhesus monkeys exhibited significant serum neutralizing antibody responses to both HSV1 and HSV2. In vitro stimulation of monkey peripheral blood leucocytes with purified gD resulted in a significant cellular proliferative response. The results obtained in these animal models with a gD subunit vaccine provide an appropriate foundation for the initiation of human studies.
    Vaccine 04/1991; 9(3):147-53. DOI:10.1016/0264-410X(91)90146-W · 3.49 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Herpes simplex virus (HSV)-immune murine splenocytes incorporated significant levels of tritiated thymidine when incubated with UV-inactivated, heat-inactivated, and active preparations of HSV. Normal splenocytes incubated with the HSV preparations did not exhibit such proliferation. Maximum incorporation by the immune splenocytes occurred on the fifth day of culture and was mediated by Thy-1+, Lyt-1+, and Lyt-2+ cells. Attempts to correlate lymphoproliferation with other HSV-specific cellular immune responses demonstrated the complexity of this response. While T cells mediating delayed type hypersensitivity responses and cytotoxic T lymphocytes were involved in the lymphoproliferative response, neither could be considered as being exclusively associated with lymphoproliferation. Instead, lymphoproliferation appeared to be indicative of HSV-specific Lyt-1+ helper cells. Evidence was also presented that suppressor cells appeared to be involved in the regulation of the lymphoproliferative response.
    Immunobiology 01/1986; 170(5):460-73. DOI:10.1016/S0171-2985(85)80069-3 · 3.18 Impact Factor
  • Source
    Genitourinary medicine 01/1990; 65(6):372-5.


Available from